Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lori Anne Kunkel currently holds 40,000 shares of Loxo Oncology, Inc. (LOXO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lori Anne Kunkel has been a net seller of LOXO stock. They have purchased $0 and sold $9.8M worth of shares.
Lori Anne Kunkel's most recent insider trade was on Jan 2, 2026, when they sold 40,000 shares at $0.00 per share.
Lori Anne Kunkel serves as Executive at Loxo Oncology, Inc. (LOXO). They have executed 33 insider transactions totaling $9.8M over their tenure at the company.
Lori Anne Kunkel holds the position of Executive at Loxo Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Lori Anne Kunkel has shown a selling trading pattern, with $0 in total purchases and $9.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lori Anne Kunkel was on Jun 14, 2018, when they sold $5.1M worth of LOXO shares. This transaction involved 28,440 shares at $180.28 per share.
Lori Anne Kunkel currently owns 40,000 shares of Loxo Oncology, Inc. (LOXO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lori Anne Kunkel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lori Anne Kunkel has 33 Form 4 filings on record as an insider at Loxo Oncology, Inc..
Set alerts for Lori Anne Kunkel and 40,000+ other insiders.